Johnson & Johnson
JNJ
#24
Rank
NZ$968.53 B
Marketcap
NZ$402.34
Share price
-0.39%
Change (1 day)
57.95%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): NZ$14.91

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is NZ$14.97. In 2025 the company made an earnings per share (EPS) of NZ$19.09 an increase over its 2024 EPS that were of NZ$11.47.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$14.91-21.91%
2025NZ$19.0966.46%
2024NZ$11.47-53.6%
2023NZ$24.72111.16%
2022NZ$11.71-13.84%
2021NZ$13.5941.81%
2020NZ$9.58-18.92%
2019NZ$11.8221.2%
2018NZ$9.751125.3%
2017NZ$0.80-92.23%
2016NZ$10.247.37%
2015NZ$9.53-4.16%
2014NZ$9.9518.1%
2013NZ$8.4224.88%
2012NZ$6.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.03-19.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-85.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.19-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.15-58.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$48.38 223.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.39-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
NZ$11.74-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$14.55-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.10-59.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.66-55.52%๐Ÿ‡ฌ๐Ÿ‡ง UK